Investment Thesis
TJX demonstrates solid fundamental strength with 7.1% revenue growth translating to 14.3% EPS growth, indicating strong operational leverage and execution. An excellent balance sheet (0.18x debt-to-equity) with $5.6B cash and 21.8x interest coverage provides financial flexibility, while positive $457M free cash flow supports the growth trajectory.
Strengths
- Strong revenue growth (7.1% YoY) with operational leverage driving EPS growth of 14.3%, exceeding revenue growth
- Fortress balance sheet with low leverage (0.18x D/E), excellent interest coverage (21.8x), and substantial cash position of $5.6B
- Healthy profitability across all margins (21.4% gross, 12.0% operating, 9.3% net) with positive free cash flow generation
Risks
- Tight working capital position (1.14x current ratio, 0.54x quick ratio) limits financial flexibility in stressed scenarios
- Modest capital efficiency with ROA of 3.7% and ROE of 12.8% indicating capital-intensive business model
- Low FCF margin of 3.2% means limited cash conversion relative to revenue size despite absolute FCF positivity
Key Metrics to Watch
- Sustained revenue growth rate and operating margin stability through economic cycles
- Free cash flow sustainability and capital expenditure intensity trends
- Working capital efficiency and inventory management as critical drivers of retail profitability
Financial Metrics
Revenue
14.3B
Net Income
1.3B
EPS (Diluted)
$1.19
Free Cash Flow
457.0M
Total Assets
36.2B
Cash
5.6B
Profitability Ratios
Gross Margin
21.4%
Operating Margin
12.0%
Net Margin
9.3%
ROE
12.8%
ROA
3.7%
FCF Margin
3.2%
Balance Sheet & Liquidity
Current Ratio
1.14x
Quick Ratio
0.54x
Debt/Equity
0.18x
Debt/Assets
0.0%
Interest Coverage
21.78x
Long-term Debt
1.9B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-30T07:33:37.052003 |
Data as of: 2026-05-02 |
Powered by Claude AI